...
首页> 外文期刊>Journal of neuroinflammation >Methylprednisolone inhibits IFN-γ and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis
【24h】

Methylprednisolone inhibits IFN-γ and IL-17 expression and production by cells infiltrating central nervous system in experimental autoimmune encephalomyelitis

机译:甲基泼尼松龙在实验性自身免疫性脑脊髓炎中抑制细胞浸润中枢神经系统的IFN-γ和IL-17表达及生产

获取原文

摘要

Background Glucocorticoids have been shown to be effective in the treatment of autoimmune diseases of the CNS such as multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE). However, the mechanisms and the site of glucocorticoids' actions are still not completely defined. The aim of this study was to investigate the in vivo effect of the synthetic glucocorticoid methylprednisolone (MP) on the expression and production of proinflammatory cytokines interferon (IFN)-γ and interleukin (IL)-17 by cells infiltrating CNS tissue. Methods Experimental autoimmune encephalomyelitis was induced in Dark Agouti (DA) rats by immunization with rat spinal cord homogenate mixed with adjuvants. Commencing on the day when the first EAE signs appeared, DA rats were injected daily for 3 days with MP and/or RU486, an antagonist of glucocorticoid receptor. Cytokine production and gene expression in CNS-infiltrating cells and lymph node cells were measured using ELISA and real time PCR, respectively. Results Treatment of rats with MP ameliorated EAE, and the animals recovered without relapses. Further, MP inhibited IFN-γ and IL-17 expression and production in cells isolated from the CNS of DA rats with EAE after the last injection of MP. The observed effect of MP in vivo treatment was not mediated through depletion of CD4+ T cells among CNS infiltrating cells, or through induction of their apoptosis within the CNS. Finally, the glucocorticoid receptor-antagonist RU486 prevented the inhibitory effect of MP on IFN-γ and IL-17 production both in vitro and in vivo, thus indicating that the observed effects of MP were mediated through glucocorticoid receptor-dependent mechanisms. Conclusion Taken together, these results demonstrate that amelioration of EAE by exogenous glucocorticoids might be, at least partly, ascribed to the limitation of effector cell functions in the target tissue.
机译:背景技术已经显示糖皮质激素可有效治疗中枢神经系统的自身免疫性疾病,例如多发性硬化及其动物模型,实验性自身免疫性脑脊髓炎(EAE)。然而,糖皮质激素作用的机制和部位仍未完全确定。这项研究的目的是研究合成的糖皮质激素甲基强的松龙(MP)对通过渗透CNS组织的细胞促炎细胞因子干扰素(IFN)-γ和白介素(IL)-17的表达和产生的体内作用。方法采用混合有佐剂的大鼠脊髓匀浆免疫法,在黑暗阿古蒂(DA)大鼠中诱发实验性自身免疫性脑脊髓炎。从首次出现EAE征兆的那一天开始,每天为DA大鼠注射3天的MP和/或RU486(糖皮质激素受体拮抗剂)。使用ELISA和实时PCR分别测量CNS浸润细胞和淋巴结细胞中细胞因子的产生和基因表达。结果MP处理对大鼠的EAE改善,动物恢复正常,无复发。此外,在最后一次注射MP后,MP抑制了从患有EAE的DA大鼠的中枢神经系统分离的细胞中IFN-γ和IL-17的表达和产生。观察到的MP体内治疗作用不是通过CNS浸润细胞中CD4 + T细胞的耗竭或通过诱导CNS内细胞凋亡来介导的。最后,糖皮质激素受体拮抗剂RU486在体外和体内均阻止了MP对IFN-γ和IL-17产生的抑制作用,从而表明观察到的MP是通过糖皮质激素受体依赖性机制介导的。结论综上所述,这些结果表明外源糖皮质激素改善EAE可能至少部分归因于靶组织中效应细胞功能的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号